Uudised  /     /   We offer the most innovative solution for acute myocardial infarction (AMI) diagnostics

We offer the most innovative solution for acute myocardial infarction (AMI) diagnostics

06 March 2023
Semetron AS

Semetron, in co-operation with device manufacturer Siemens Healthineers, offers the most innovative solution for acute myocardial infarction (AMI) diagnostics – the Atellica® VTL. The device is able to determine high-sensitivity troponin I levels in capillary whole blood in a near-patient setting in just 8 minutes. The Atellica® VTLi wireless device can be easily integrated into the workflow of hospitals and clinics. The new solution will help streamline primary diagnostics in overcrowded emergency care centres.

Vaata lähemalt

More news

Projects
Semetron advised the Ülemiste Surgery Clinic in the planning phase and carried out a medical technology project for the clinic.

Within the framework of the project, the technical requirements for... View Article

Press releases
The field hospital donated as a cooperation between Estonia, Norway and the Netherlands arrived in Ukraine

The Republic of Estonia Centre for Defence Investment, in co-operation... View Article

Company news
We offer the most innovative solution for acute myocardial infarction (AMI) diagnostics

Semetron, in co-operation with device manufacturer Siemens Healthineers, offers the... View Article